abrdn Life Sciences Investors (HQL) Stock Price
HQLStock
$16.78+1.21%52W
Market Cap$510.25M
P/E5.71x
PEG Ratio—
Div yield—
Beta0.73
HQL Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-15.37%
Price vs S&P 500 (4W)-13.02%
VGM Score53.62
P/E Ratio (Annual)5.71x
Industry Peers — Unclassified(48)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | ROE (TTM) | Revenue Growth (5Y) | Indicated Dividend Yield (Annual) | Price |
|---|---|---|---|---|---|---|---|---|
HQLabrdn Life Sciences Investors | C | B | D | 5.7x | 36.8% | 11.9% | — | $16.78 |
| NVGNuveen AMT-Free Municipal Credit Income Fund | C | C | D | 40.0x | 7.0% | -1.7% | — | $10.89 |
| CLMCornerstone Strategic Investment Fund, Inc. | — | — | F | — | — | — | — | $6.18 |
| TYTRI-Continental Corporation | A | B | B | 7.6x | 24.6% | 1.8% | — | $34.60 |
| CETCentral Securities Corp. | F | B | B | 7.3x | 17.5% | 1.7% | — | $55.40 |
| MQYBlackrock Muni Yield Quality Fund, Inc | D | C | D | — | 1.7% | 14.6% | — | $10.30 |
| GAMGeneral American Investors Company, Inc. | — | — | B | 5.1x | — | — | — | $64.16 |
| MYIBLACKROCK MUNIYIELD QUALITY FUND III, INC. | D | C | C | — | 2.2% | -2.7% | — | $9.86 |
| HQHabrdn Healthcare Investors | D | B | C | 11.0x | 22.6% | 8.7% | — | $18.98 |
| MYNBLACKROCK MUNIYIELD NEW YORK QUALITY FUND, INC. | — | — | D | — | -0.4% | — | — | $8.91 |
| MUABlackrock Muni Assets Fund, Inc. | D | C | D | — | 2.8% | 0.8% | — | $9.44 |
About abrdn Life Sciences Investors
abrdn Life Sciences Investors is a non-diversified, closed-end fund focused on long-term capital appreciation in the life sciences sector. It invests in both public and private companies with above-average growth potential. The fund's strategy targets companies believed capable of delivering superior returns.